
BASF is preparing to return to Evonik Industries with a new offer and has been sounding out German lawmakers on the plan, a draft proposal shows, extending a takeover contest between two of the country’s largest chemical groups.
The renewed approach follows a bid that Evonik’s board turned down. In late October, BASF lifted its proposal to roughly €24 per Evonik share, up from an earlier figure of about €22.15, for a total of just over €11 billion. The earlier proposal valued Evonik at about €10.3 billion. The €24 level represents a premium of almost 40% to Evonik’s share price before BASF disclosed its interest in September. Neither company has confirmed the price publicly, and Evonik has said it intends to keep developing as an independent company.
The political groundwork is central to the effort. RAG-Stiftung, the foundation that funds the long-term costs of Germany’s former hard-coal industry, holds about 43% of Evonik and is its largest shareholder. Its 13-member board of trustees is made up largely of politicians, and five seats are held ex officio, including the prime ministers of North Rhine-Westphalia and Saarland, the federal economics and finance ministers and the head of the IG BCE union. The foundation’s support is needed for a deal to succeed, and some of its members want to protect jobs and sites.
BASF Chief Executive Markus Kamieth has tried to address the job concerns that weigh on that audience. He has pledged no compulsory redundancies until 2032, adoption of existing collective bargaining and site agreements, continued investment in apprenticeships, and a continuing role for Evonik’s Essen headquarters, including at least one executive board portfolio based there. He has also said BASF will not buy Evonik at any price and has called consolidation in the sector inevitable.
Evonik shares rose more than 3% to €21.34 in Frankfurt on Oct. 23 on reports of the higher bid, still about 12% below the reported €24 level. Several details complicate the picture. Evonik has been planning to sell Syneqt, the operator of its chemical parks, which employs about 3,500 people. Kamieth has said BASF believes it could run the Marl and Wesseling parks itself, while Syneqt has told media it intends to remain independent even if BASF takes over Evonik. Evonik has also outlined terms for asset sales since BASF’s approach became public.
Less widely noted is that Evonik has been exploring its own acquisition, of the U.S. specialty chemicals company Ashland, which is being offered for sale. That interest is reported to have alarmed BASF, and a completed purchase could change the size and shape of the target before any formal offer is made.
BASF’s own rationale rests on mix. Evonik’s business is concentrated in specialty products such as additives, adhesive raw materials and high-performance plastics, while BASF is trying to reduce its reliance on bulk chemicals at a time of high energy prices, weak demand and competition from Asian and Middle Eastern producers. BASF has stressed that its public statements are not an offer and that formal terms would appear only in an offer document.
The two groups also overlap in Antwerp, where BASF runs its second-largest production complex worldwide with more than 3,000 employees and over 50 plants. Evonik’s biggest site outside Germany is nearby at Lillo, with more than 900 employees, and it is unclear whether BASF’s German job guarantees would extend to either location.
Sources: Bloomberg, chemicalprocessing.com, industrylinqs.com.









